Synthesis of the long boronic ester amines for coupling tert-Butyl 2-(2-hydroxyethoxy)ethylcarbamate
To a solution of di-tert-butyl dicarbonate (21.83 g, 100 mmol, 1 eq) in CH 2 Cl 2 (70 mL) on ice was added 2-(2-aminoethoxy)ethanol (12.0 mL, 12.6 g, 120 mmol, 1.2 eq) dropwise, subsequently NEt 3 (27.8 mL, 20.24 g, 200 mM, 2 eq). The resulting mixture was stirred at rt for 3 h. The reaction was quenched with sat. NH 4 Cl, diluted with EtOAc (400 mL), washed with sat. NH 4 Cl (2x200 mL) and brine (200 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The title compound was obtained as a clear oil (18.2 g, 88.7 mmol, 89%) and was used in the next step without further purification. 1 .
2-(2-(tert-Butoxycarbonylamino)ethoxy)ethyl methanesulfonate
To a solution of tert-butyl 2-(2-hydroxyethoxy)ethylcarbamate (17.8 g, 87 mmol, 1 eq) in 100 mL CH 2 Cl 2 at 0°C was added NEt 3 (26.7 mL, 19.4 g, 191 mmol, 2.2 eq) and then dropwise CH 3 SO 2 Cl (7.4 mL, 11 g, 96 mmol, 1.1 eq). The cloudy yellow solution was stirred on ice for 5 h and then quenched with sat. NH 4 Cl. The reaction was then diluted with EtOAc (400 mL), washed with sat. NH 4 Cl (200 mL), NaHCO 3 (200 mL) and brine (200 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The product was purified by column chromatography (Biotage KP-SIL SNAP 100 g cartridge 0-50% over 10CV EtOAc in petrol) yielding the title compound (18.35 g, 65 mmol, 75%) 
tert-Butyl 2-(2-(prop-2-ynyloxy)ethoxy)ethylcarbamate
To a solution of propargylic alcohol (5.24 mL, 5.05 g, 90 mmol, 3 eq) in 100 mL THF on ice was added NaH (2.16 g, 90 mmol, 3 eq) portion wise. The resulting suspension was stirred on ice for 30 min then 2-(2-(tert-butoxycarbonylamino)ethoxy)ethyl methanesulfonate (8.5 g, 30 mmol, 1 eq) was added dropwise. The resulting suspension was stirred at rt for 19 h. The reaction was then quenched with sat. NH 4 Cl (10 mL) and solvents were removed in vacuo. The resultant red liquid was partitioned between H 2 O (50 mL) and EtOAc (350 mL). The organic phase was washed with sat. NH 4 Cl (100 mL), sat. NaHCO 3 (100 mL) and brine (100 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. .
(E)-tert-Butyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyloxy)ethoxy) ethylcarbamate [3b]
To neat tert-butyl 2-(2-(prop-2-ynyloxy)ethoxy)ethylcarbamate (4.86 g, 20 mmol, 1 eq) was added pinacolborane (3.5 mL, 3.07 g, 22 mmol, 1.1 eq), NEt 3 (270 uL, 202 mg, 2 mmol, 0.1 eq) and ZrCp 2 HCl (516 mg, 2 mmol, 0.1 eq). The solution was stirred at 65°C for 17 h. After completion the reaction was allowed to cool to rt and was diluted with EtOAc (25 mL) and quenched with sat. NH 4 Cl. The mixture was further diluted with EtOAc (150 mL) and the organic layer was washed with sat. NH 4 Cl (50 mL), sat. NaHCO 3 (50 mL) and brine (50 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The product was purified by automated column chromatography (Biotag SNAP 100g cartridge 5-50% over 10CV EtOAc in petrol) yielding the title compound as a yellow oil (6.5 g, 17.5 mmol, 88% 
(E)-2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyloxy)ethoxy)ethanamine (S2)
(E)-tert-Butyl-2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyloxy)ethoxy)ethylcarbamate (3.71 g, 10 mmol) was dissolved in 10% CF 3 COOH in CH 2 Cl 2 (50 mL total). The solution was then stirred for 3 h. The solvents were removed in vacuo and CF 3 COOH was subsequently co-evaporated with toluene (2x30 mL) and CH 2 Cl 2 (3x30 mL) yielding S2 (3.41 g, 8.9 mmol, 89%) as a brown oil. 
Amide couplings 3-(3-Methyl-3H-diazirin-3-yl)propanoic acid (S3) [4]
To NH 3 (150 mL) was added leuvenic acid (17.4 g, 150 mmol, 1 eq) at -78°C. The resulting clear solution was stirred at -50 to -40°C for 3.45 h. During this time a white precipitate was formed. The reaction mixture was then cooled to -78°C again and hydroxylamine-O-sulfonicacid (20.36 g, 180 mmol, 1.2 eq) in MeOH (150 mL) was added dropwise over 20 min. The reaction mixture was stirred at -78°C for 1.10 h and then let come to rt overnight. Most MeOH was removed in vacuo and the residue was taken up in MeOH (50 mL). NEt 3 was added and the resulting mixture was stirred at 0°C for 15 min. Solvents were removed in vacuo and the residue was taken up in MeOH (150 mL) and cooled to 0°C. NEt 3 (60 mL) was added and then I 2 was added in portions. The addition was continued until the colour of iodine persisted (total 33.2 g, 131 mmol). The reaction mixture was stirred at rt for 20 min. Subsequently, the solvents were removed and the residue was partitioned between Et 2 O and water. The aqueous layer was acidified with 5M HCl and extracted with Et 2 O (2x150 mL). The combined organic layers were washed with 20% NaHSO 3 and brine, dried (MgSO 4 ) filtered and solvents were removed in vacuo yielding sufficiently pure S3 as a yellow oil (solidifies at -20°C; 7.82 g, 61 mmol, 40% yield 
(E)-3-(3-Methyl-3H-diazirin-3-yl)-N-(2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyloxy)ethoxy)ethyl)propanamide (4)
To a solution of S3 (769 mg, 6 mmol, 1.5 eq) in CH 2 Cl 2 (20 mL) on ice was added N,N'-dicyclohexylcarbodiimide (DCC; 1.32 g, 6.4 mmol, 1.6 eq). The resulting solution was stirred on ice for 30 min and then 4-dimethylaminopyridine (DMAP; 244 mg, 2 mmol, 0.5 eq) and N,Ndiisopropylethylamine (DIPEA; 1.4 ml; 1.03 g, 8 mmol, 2 eq) and S2 (1.54 g, 4 mmol, 1 eq) were added. The reaction mixture was stirred at rt overnight and then filtered (wash with EtOAc or Et 2 O) and diluted with EtOAc (100 mL). The organic phase was washed with sat. NH 4 Cl (50 mL), sat. NaHCO 3 (50 mL) and brine (50 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The residue was purified by automated column chromatography (Biotag SNAP 25 g cartridge 0-10% over 10 CV MeOH in CH 2 Cl 2 ) yielding 4 (738 mg, 2.1 mmol, 35%) as a brown oil. 
(E)-3-(3-Methyl-3H-diazirin-3-yl)-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)propanamide (5)
To a solution of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC.HCl; 422 mg, 2.2 mmol, 2.2 eq) in CH 2 Cl 2 (15 mL) on ice was added S3 (256 mg, 2 mmol, 2 eq). The resulting mixture was stirred on ice for 30 min and then 4-dimethylaminopyridine (DMAP; 49 mg, 0.4 mmol, 0.4 eq) and N,N-diisopropylethylamine (DIPEA; 435 µL, 323 mg, 2.5 mmol, 2.5 eq) and S1 (297 mg, 1 mmol, 1 eq) were added. The reaction mixture was stirred at rt overnight then quenched with NH 4 Cl (sat., 20 mL) and diluted with EtOAc (80 mL). The organic phase was washed with sat. NH 4 Cl (2x30 mL), sat. NaHCO 3 (30 mL) and brine (30 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The residue was purified by automated column chromatography (Biotag SNAP 25g cartridge 0-10% over 10 CV MeOH in CH 2 Cl 2 ) yielding 5 (266 mg, 0.91 mmol, 91%) as a brown oil. 
(E)-4-Benzoyl-N-(2-(2-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)ethoxy)ethyl)benzamide (6)
To a solution of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC.HCl; 211 mg, 1.1 mmol, 2.2 eq) in CH 2 Cl 2 (10 mL) on ice was added 4-benzoylbenzoic acid (226 mg, 1 mmol, 2 eq). The resulting solution was stirred on ice for 30 min and then 4-dimethylaminopyridine (DMAP; 31 mg, 0.25 mmol, 0.5 eq) and N,N-diisopropylethylamine (DIPEA; 304 µL, 226 mg, 1.75 mmol, 3.5 eq) and S2 (192 mg, 0.5 mmol, 1 eq) were added. The reaction mixture was stirred at rt overnight then quenched with NH 4 Cl (sat., 20 mL) and diluted with EtOAc (80 mL). The organic phase was washed with sat. NH 4 Cl (2x30 mL), sat. NaHCO 3 (30 mL) and brine (30 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The residue was purified by automated column chromatography (Biotag SNAP 25g cartridge 0-5% over 10 CV MeOH in CH 2 Cl 2 ) to give 6 (86 mg, 0.18 mmol, 36% 
4-((E)-Phenyldiazenyl)-N-((E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)benzamide (7)
To a solution of 4-(phenyldiazenyl)benzoic acid (226 mg, 1 mmol, 2 eq) in dry Tetrahydrofuran (10 mL) was added N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC.HCl; 211 mg, 1.1 mmol, 2.2 eq) at 0°C under N 2 . The resulting solution was stirred for 30 min at 0°C and then S1 (149 mg, 0,5 mmol, 1 eq), N,N-diisopropylethylamine (DIPEA; 325 uL, 1.75 mmol, 3.5 eq) and 4-dimethylaminopyridine (DMAP; 25 mg, 0.2 mmol, 0.4 eq) were added. The reaction mixture was allowed to warm to rt and stirred for 16 h. Solvents were removed in vacuo and the red oil was taken up in EtOAc (150 mL). The organic layer was washed with sat. NH 4 Cl (2 x 50 mL), sat. NaHCO 3 (50 mL) and brine (50 mL); dried (MgSO 4 ), filtered and solvents were removed in vacuo. The red residue was purified by automated column chromatography (Biotage SNAP 10g; MeOH in CH 2 Cl 2 ; 0% 5CV; 0-5% 10CV) yielding 7 a deep red solid ( trans:cis ; 7:1; 76 mg, 0.2 mmol, 39% (t, J=6 Hz, 1x0.15 H, NH) 6.48 (t, J=6 Hz, 1 H, NH) 6. 1x0.15 H, CH) 6.65 -6.76 (m, 1 H, CH) 6. 4x0.15 H, 1x0.15 H, 2x0.15 H, 3 H, ArH) 7.68 (d, J=9 Hz, 2x0.15 H, ArH) 7.88 -8.00 (m, 6 H, ArH); 13 C NMR (101 MHz, CDCl 3 ) d ppm 24.7 (CH 3 ) 43.4 (CH 2 ) 83.4 (CCH 3 ) 119.1 (CH) 120.2 (Ar-CH (minor)) 120.6 (Ar-CH (minor)) 122.9 (Ar-CH (major)) 123.0 (Ar-CH (major)) 127.7 (Ar-CH (minor)) 127.9 (Ar-CH (major)) 128.8 (Ar-CH (minor)) 129.1 (Ar-CH (major)) 131.5 (Ar-CH (major)) 136 (Ar-C) 148.1 (CH) 152.4 (Ar-C) 154.2 (Ar-C) 166. 414.1963; IR (neat): 3316, 2928 IR (neat): 3316, , 2360 IR (neat): 3316, , 2341 IR (neat): 3316, , 1640 IR (neat): 3316, , 1541 .
(E)-N-(3-(4,4,5,5-tetra-Methyl-1,3,2-dioxaborolan-2-yl)allyl)pyrene-2-carboxamide (10)
To a solution of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC·HCl, 211 mg, 1.1 mmol, 2.2 eq) in CH 2 Cl 2 (10 mL) on ice was added pyrene-2-carboxylic acid (246 mg, 1 mmol, 2 eq). The resulting solution was stirred on ice for 30 min and then 4-dimethylaminopyridine (DMAP; 25 mg, 0.2 mmol, 0.4 eq) and N,N-diisopropylethylamine (DIPEA; 304 µL, 226 mg, 1.75 mmol, 3.5 eq) and S1 (150 mg, 0.5 mmol, 1 eq) were added. The reaction mixture was stirred at rt overnight, then quenched with NH 4 Cl (sat., 20 mL) and diluted with EtOAc (80 mL). The organic phase was washed with sat. NH 4 Cl (2x30 mL), sat. NaHCO 3 (30 mL) and brine (30 mL), dried (MgSO 4 ), filtered and solvents were removed in vacuo. The residue was purified by automated column chromatography (Biotag SNAP 25g cartridge 0-5% over 10 CV MeOH in CH 2 Cl 2 ) yielding 10 (120 mg, 0.29 mmol, 58%) as a yellow foam. Small molecule cross-couplings 5-Phenyl-2'-deoxyuridine (1) [5] 5-Iodo-2'-deoxyuridine (53 mg, 0.15 mmol, 1 eq), phenylboronic acid (28 mg, 0.23 mmol, 1.5 eq) and K 2 CO 3 were assembled in a 15 mL vial. 2 mL ddH 2 O, 0.5 mL MeCN and Pd*L1 (150 µL of a 0.05 M stock, 7.5 µmol, 5 mol%) were added. The vial was flushed with argon, closed and heated to 55°C for 5 h. The reaction mixture was allowed to cool down to rt, acidified with 2 M HCl (2 drops) and extracted with CH 2 Cl 2 (3x10 mL). The combined organic phases were washed with brine, dried over MgSO 4 and the solvent was removed in vacuo. The crude product was purified by column chromatography (CH 2 Cl 2 >9:1 CH 2 Cl 2 :MeOH) yielding 1 as colorless oil (36 mg, 0.12 mmol, 80% 
N-(2-(2-((E)-3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyloxy)ethoxy)ethyl)-3-(3-methyl-3H-diazirin-3-yl)propanamide (2)
5-Iodo-2'-deoxyuridine (38 mg, 0.1 mmol, 1 eq) and K 2 CO 3 (41 mg, 0.3 mmol, 3 eq) were dissolved in 4 mL 3:1 H 2 O:MeCN in a 10 mL vial. To the stirred solution was added Pd*L1 (100 µL of a 0.05 M stock, 5 µmol, 5 mol%) and subsequent 4 (57 mg, 0.15 mmol, 1.5 eq). The reaction mixture was stirred at 55°C for 2h after which TLC indicated complete conversion. 
N-((E)-3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)allyl)-3-(3-methyl-3H-diazirin-3-yl)propanamide (3)
5-Iodo-2'-deoxyuridine (28.3 mg, 0.08 mmol, 1 eq) and K 2 CO 3 (33.2 mg, 0.24 mmol, 3 eq) were dissolved in 4 mL 3:1 H 2 O:MeCN in a 10 mL vial. To the stirring solution was added Pd*L1 (80 µL of a 0.05 M stock, 4 µmol, 5 mol%) and subsequent 3 (35.2 mg, 0.12 mmol, 1.5 eq). The reaction mixture was stirred at 50°C for 4h. The solvents were removed in vacuo and the residue was dissolved in MeOH (30 mL), filtered and purified by automated column chromatography (Biotag SNAP 10 g cartridge 0-20% over 20 CV MeOH in CH 2 Cl 2 ) yielding an inseparable mix of 5c and starting material (30 mg, 76 µmol, 95%, 60% 3 as determined by NMR) as a yellow oil. 
Catalyst preparation
To 2-aminopyrimidine-4,6-diol (65 mg, 0.5 mmol, 2 eq, R = H) or 2-(dimethylamino)pyrimidine-4,6-diol ( 78 mg, 0.5 mmol, 2 eq, R = Me) in a 5 mL volumetric flask was added H 2 O (3 mL) and NaOH (10 M stock, 100 µL, 1 mmol, 4 eq). The solution was stirred for ~5 min at rt until all solids were dissolved. Then Pd(OAc) 2 (55 mg, 0.25 mmol, 1 eq) was added and the flask was stoppered and stirred at 65°C for 60 min. The stirring bar was removed and the solution was adjusted to 5 mL with H 2 O to give a 50 mM stock solution.
ODN crosscoupling
General reaction conditions Unless otherwise noted, 100 µM ODN1-4, 50 mM Tris pH 8.5, 10-50 µM Pd(OAc) 2 LX 2 and 10 mM boronic ester were combined in an eppendorf tube and shaken for 4h at 37°C in an incubator. Then the reaction was spun down (2 min, 16000 x g) and the supernatant was analyzed by HPLC and MS. Sometimes precipitation is observed after 24h in the catalyst stock solution. In these cases, probably due to lower actual concentration, the reaction proceeds better with 1 eq (100 µM) Pd(OAc) 2 LX 2 .
ODN1a
ODN1a elutes at 26.69 min. The peak at 27.29 is a small molecule impurity. Gradient is 5%-20% B in 30 min. Calc 1728.2 found 1728.7
ODN1c
Product elutes at 16 min. Gradient is 0%-30% B in 30 min. Calc 1718.2 found 1717.4
ODN1e
Product elutes at 12.3 min. Gradient is 5%-40% B in 20 min. ODN1e reaction with 3-furane boronic acid
Product elutes at 15.8 min, the product of deiodination at 12.6 min. Gradient is 5%-20% B in 20 min.
ODN1f
Product elutes after 26 min. Gradient is 5%-20% B in 30 min. 
ODN1g
The reaction was performed in 40% MeCN. Product elutes at 27.3 min. Gradient is 5%-30% B in 30 min. 
ODN1 reaction intermediates by ESI-MS
The PdOAc 2 L1 2 species for this reaction was prepared as describe previously, but substituting NaOH with NH 4 OH (33%). The reaction was conducted as described in the general reaction conditions, but using 10 mM NH 4 OAc buffer (pH 8.5) and 100 µM Pd PdOAc 2 L1 2 (1 eq relative to ODN1). The reaction was allowed to proceed for 30 min at 37°C. Then, particulates were removed by centrifugation (2 min, 16k x g) and 10 µL of the reaction mixture were injected into the LCT (ESI-) with the autosampler using a flow of 50:50 H 2 O:MeOH (200 µL/min). While more Pd containing species can be observed, these could not be unambiguously identified.
ODN2 (no IdU control)
ODN2 elutes at 31.8 min. Gradient is 0%-20% B in 40 min.
Before reaction:
After the reaction:
ODN3b
The Product elutes at 18.4 min. ODN was separated on a gradient of 5%-20% B in 20 min. Calc. 4232 found 4232
ODN3c
The Product elutes at 16.9 min. ODN was separated on a gradient of 0%-40% B in 30 min. Calc. 4222 found 4222
ODN3f
The Product elutes at 14.2 min. ODN was separated on a gradient of 5%-20% B in 20 min. Calc. 4135 found 4135
P short diaz

ODN4 control reactions
Control reactions were set up as described in the general procedure omitting one component where stated. Boronic ester 2 was used for these experiments.
ODN was separated on a gradient of 0%-20% B in 40 min. The starting material elutes at 36.4 min and the product at 40.5 min.
Starting material:
No Boronic ester:
No Palladium:
All components:
ODN4 -Phosphate and Tris buffer comparison
Reactions were conducted as described in the general procedure but in 100mM PO4 pH 8. Calc. 1628 found 1628 dsDNA crosscoupling ODN3 was annealed with the appropriate complementary strand (CTACTGCATCGGT; predicted melting temperature 43°C) by cooling a 150µM solution of each ODN in annealing buffer (10 mM TRIS pH 7.5, 100 mM NaCl) from 90°C to 4°C at 1°C per minute in a PCR block. The resulting dsODN was used as substrate for the crosscoupling reaction under the standard conditions (100 µM dsODN, 100 µM PdOAc 2 L2 2 , 10 mM 5, 50 mM TRIS pH 8.5) and was shaken at 37°C for 16h. The resulting mixture was analyzed by PAGE (15%, 0.5x TBE; stained with Sybr safe), HPLC (10%-30% buffer B in 20 min) or denaturing HPLC (column was heated at 50°C; 10%-20% B in 30 min). Chromatograms and gel are shown below.
PCR probe generation
Following template (T1: GCT GCC TGG ACT GAC CTC ACA TGA CCT TAC GCG CAG AGA  CCT AGA CAG TGC TTC AGG) and Primers (ODN4d and P2: GCT GCC TGG ACT GAC CTC  ACA TGA CC) were used. The PCR was performed with Vent exo -(NEB, M0257S) using the manufacturers recommended buffers and dNTP concentrations. Temperature cycle for the PCR was as follows (55°C, 20 sec; 72°C, 30 sec; 95°C, 15 sec) and was repeated 40x. The PCR product was purified by phenol extraction and ethanol precipitation. 
Photocrosslinking
Nuclear extract was prepared using the NE-PER kit (Pierce, 78833) from two confluent 145 mm petridishes HeLa cells using the manufacture recommended procedure. Obtained nuclear extract was dialyzed into cross linking buffer (25 mM TRIS pH 7.5, 100 mM NaCl, 1 mM EDTA, 2 mM MgCl 2 , 0.5 mM DTT, 20% glycerol and one Complete Protease Inhibitor (Pierce, without EDTA) per 50 mL) for 3h. The obtained extract was pre-cleared with Captavidin beads (50 µL, life technology, C-21386), by incubation for 1:30 h at 4°C. The beads were removed by centrifugation and Probes were added (3 nmol, purified from PCR). The mixture was incubated for 20 min on ice and then irradiated for 30 min at 311 nm (caprobox; Caprotec) for silac experiments or at 365 nm using a handheld UV lamp (8W). The solution was adjusted to 1M NaCl and Dynabeads® MyOne™ Streptavidin T1 (200 µL, life technology, 65601) were added. Binding was performed on at room temperature for 1.30 h under constant agitation. The beads were immobilized on DynaMag™-Spin Magnet (life technology, 12320D), and washed with wash buffer (10 mM TRIS, 1 mM EDTA, 1 M NaCl) three times and with wash buffer + 6 M Urea two times. The proteins were released by boiling in Laemli loading buffer for 10 min and separated on a 4-12% gradient gel (NuPAGE® Novex® 4-12% Bis-Tris Gel, Invitrogen). The gel was either visualized by silver stain (Pierce Silver Stain Kit, Thermo Scientific, 24612) or transferred to PVDF membrane using the iBlot (Invitrogen). The membrane was then blocked (3% BSA in TBS-T) for 30 min at room temperature, washed 5 times with TBS-T and then incubated with ExtrAvidin® -Alkaline Phosphatase (Sigma, E2636) for 1h at room temperature. The membrane was then again washed with TBS-T (5x) and water (3x) before visualizing with the BCIP/NBT Liquid Substrate System (Sigma, B1911).
For SILAC experiments the hmC containing probe was incubated and cross-linked with unlabeled cell lysate and the C containing probe with isotope labeled cell lysate (Arg10 and Lys8) for the forward experiment. For the reverse experiment, heavy and light cells were switched. After crosslinking the mixtures were pooled and processed together as described above. After SDS-PAGE the gel was stained with coomassie blue, cut in slices and tryptic digest was performed as described elsewhere (http://www.ccmp.ox.ac.uk/protocols-and-tools).
Streptavidin blot
Supplementary Results
SILAC experiments were carried out twice, the first time where the DNA probe containing CTP was incubated with extracts prepared from cells labeled with heavy amino acid isotopes (heavy), whereas extracts from unlabeled cells (light) were incubated with the dhmCTP containing DNA probe. In the second experiment, extracts prepared from heavy labeled cells were incubated with the hmCTP DNA probe and unlabeled cell extracts with the CTP DNA probe. This allowed the SILAC mass spectrometry analysis to be performed in forward and reverse ratios, and proteins differentially present would be expected to exert inverted abundance ratios between the two SILAC experiments (Supplementary Tables 2 A and B) . This strategy allowed the elimination of potential "false positives", and led to the selection of DNA interacting proteins identified and quantified with complementary abundance ratios (Supplementary Table 1) . A number of DNA-binding proteins were identified including p20-CGGBP, p52/p100, DHX 9, DDX3X and LIG3 (Supplementary Table 1 ).
CGG triplet repeat-binding protein 1 (P20-CGGBP) binds sequence-specifically to the doublestranded trinucleotide repeat 5'-d(CGG)-3'. [6] Interestingly, the binding is inhibited by complete or partial cytosine-specific DNA methylation of the binding motif in the promoter of the fragile X mental retardation 1 (FMR1) gene, [7] whilst we observed enrichment of p20-CGGBP in hmC versus C containing DNA probes (Supplementary Table 1 ).
Supplemental Figure S4 Biotin western blot of the photo-crosslinking reaction in HeLa nuclear extract using hmC or C containing probes (lane 2 and 3) and the control without UV irradiation (lane 4). Only upon irradiation covalent DNA-Protein conjugates are observed. Table 2 ).
Supplementary
The ATP-dependent helicases DHX9 and DDX3X were also found to be enriched with hmC containing DNA probes (Supplementary Table 2 ). Both enzymes unwind DNA and are part of mRNP complexes involved in target gene activation. [9] [10] 12] In addition, we found the two components of the SFPQ-NONO complex, which is a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ) subunits. NONO is a component of spliceosome and U5.4/6 snRNP complexes. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1, but also in DNA nonhomologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends. [8] Nothing is known for these proteins identified in our SILAC screen in terms of specific recognition of hmC modifications, but our results indicate potential functional connections that warrant further investigation in hmC associated DNA modification biology, in particular in CpG islands.
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